Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer

通过工程改造NKG2D配体亲和力，可将靶向EGFR的NK细胞衔接器转化为对抗胰腺癌的高效效应因子。